[144] Xometry, Inc. SEC Filing

Rhea-AI Filing Summary

Xometry, Inc. (XMTR) Form 144 notice reports a proposed sale of 598 shares of Class A Common stock through UBS Financial Services on NASDAQ, with an aggregate market value of $32,196 and an approximate sale date of 10/01/2025. The filer acquired the shares as a stock award on 01/01/2025 from the issuer and indicates payment date as 01/01/2025. The filing also discloses a prior sale of 598 shares on 09/02/2025 that generated gross proceeds of $30,048.06. The form includes the standard signer representation that the seller is not aware of undisclosed material adverse information.

Positive

• Full disclosure of acquisition date, nature of acquisition (stock award), broker, and proposed sale details
• Attestation that the seller is not aware of undisclosed material adverse information, supporting compliance

Negative

• None.

Insights

Securities Analyst

TL;DR Routine Rule 144 sale of recently awarded shares; small, transparent transaction with limited apparent market impact.

The filing documents a proposed sale of 598 Class A shares (market value $32,196) executed through UBS and an earlier sale of the same quantity on 09/02/2025 for $30,048.06. The shares were acquired as a stock award on 01/01/2025, which typically indicates insider compensation rather than an open-market accumulation. No financial results, litigation, or other material events are disclosed, so this appears to be an individual liquidity event rather than a company-level development.

Corporate Governance Expert

TL;DR Disclosure aligns with Rule 144 compliance; signature attests to absence of undisclosed material information.

The filer provided required details including acquisition date, nature of acquisition (stock award), broker, and planned sale date, and executed the attestation about material adverse information. This supports regulatory transparency and adherence to insider sale procedures. The filing contains no indication of a trading plan date under Rule 10b5-1, and no other governance or control changes are reported.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A Common	UBS Financial Services, Inc. 11 Madison Avenue 4th Floor New York NY 10010	598	32196.00	49339037	10/01/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Class A Common	01/01/2025	Stock Award	Issuer			598	01/01/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
James Miln 6116 EXECUTIVE BOULEVARD, SUITE 800 NORTH BETHESDA MD 20852	Class A Common	09/02/2025	598	30048.06

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the XMTR Form 144 announce?

The form announces a proposed sale of 598 Class A Common shares through UBS on NASDAQ with an aggregate market value of $32,196 and an approximate sale date of 10/01/2025.

How and when were the shares being sold acquired?

The shares were acquired as a stock award on 01/01/2025 from the issuer, with the filing showing acquisition and payment dated 01/01/2025.

Has the filer sold any XMTR shares recently?

Yes. The filing discloses a sale of 598 shares on 09/02/2025 that produced gross proceeds of $30,048.06.

Through which broker will the planned sale occur?

The planned sale is to be executed through UBS Financial Services, Inc., 11 Madison Avenue, New York, NY.

Does the filing indicate any undisclosed material information about XMTR?

By signing, the person represents they do not know of any material adverse information about the issuer that has not been publicly disclosed.